Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference10 articles.
1. A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
2. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
3. The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
4. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
5. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies;Molecules;2024-01-22
2. LSD1 in drug discovery: From biological function to clinical application;Medicinal Research Reviews;2023-11-28
3. LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study;Molecules;2023-07-10
4. LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials;Frontiers in Pharmacology;2023-02-02
5. Targeting the LSD1/KDM1 Family of Lysine Demethylases in Cancer and Other Human Diseases;Targeting Lysine Demethylases in Cancer and Other Human Diseases;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3